AKT1 and cancer: The Rac wild type (FPG) peptide was only recognized when co-cultured with the T cells in the highest peptide concentrations of 10-6 M. Since the Rac2P29L mutation is less common in human cancers, the subsequent experiments focused primarily on the Rac1P29S mutation as a target for ATT.